Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods-Reference-Cited by-同舟云学术

Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods

Published:2016 Issue: Volume: Page:87-101
ISSN:0065-2598
Container-title:Emerging and Re-emerging Viral Infections
language:
Short-container-title:

Author:

Warner Bryce M.,Safronetz David,Kobinger Gary P.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/5584_2016_135

Reference73 articles.

1. Arsenault R, Griebel P, Napper S (2011) Peptide arrays for kinome analysis: new opportunities and remaining challenges. Proteomics 11(24):4595–4609

2. Arsenault RJ, Li Y, Maattanen P et al (2013) Altered Toll-like receptor 9 signaling in Mycobacterium avium subsp. paratuberculosis-infected bovine monocytes reveals potential therapeutic targets. Infect Immun 81(1):226–237

3. Bhathena J, Kulamarva A, Martoni C et al (2011) Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. Diabetes Metab Syndr Obes 4:195–203

4. Blaschke V, Reich K, Blaschke S et al (2000) Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology. J Immunol Methods 246(1):79–90

5. Boguski MS, Lowe TM, Tolstoshev CM (1993) dbEST—database for “expressed sequence tags”. Nat Genet 4(4):332–333

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters;Journal of Virology;2024-09-04

2. Non-classical animal models for studying adrenal diseases: advantages, limitations, and implications for research;Laboratory Animal Research;2024-06-19

3. Models of Herpes Simplex Virus Latency;Viruses;2024-05-08

4. Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamsters;2024-02-09

5. Current state-of-the-art and potential future therapeutic drugs against COVID-19;Frontiers in Cell and Developmental Biology;2023-08-25